Head-to-Head Trial of Botulinum Neurotoxin Type A Products for Frown Lines
A multicenter, triple-blind, randomized controlled trial is currently being conducted to evaluate the effectiveness and safety of all commercially available Botulinum Neurotoxin Type A (BoNT-A) products for the treatment of glabellar rhytides.